10x Genomics Revenue 2018-2024 | TXG

10x Genomics revenue from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

10x Genomics Revenue 2018-2024 | TXG

10x Genomics revenue from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$11.4B
Inspire Medical Systems (INSP)$5.9B
Hims & Hers Health (HIMS)$5B
Axonics (AXNX)$3.6B
IRhythm Technologies (IRTC)$2.7B
Enovis (ENOV)$2.6B
Privia Health (PRVA)$2.5B
Omnicell (OMCL)$2.3B
Azenta (AZTA)$2.2B
Clover Health Investments (CLOV)$1.7B
Schrodinger (SDGR)$1.4B
Phreesia (PHR)$1.2B
Standard BioTools (LAB)$800M
Fulgent Genetics (FLGT)$589M
Butterfly Network (BFLY)$558M
Talkspace (TALK)$555M
Definitive Healthcare (DH)$500M
Health Catalyst (HCAT)$498M
Pulmonx (LUNG)$294M
SOPHiA GENETICS SA (SOPH)$230M
TruBridge (TBRG)$203M
American Well (AMWL)$135M
P3 Health Partners (PIII)$134M
EUDA Health Holdings (EUDA)$108M
HeartBeam (BEAT)$68M
Future Health ESG (FHLT)$65M
111 (YI)$59M
Zepp Health (ZEPP)$49M
SHL Telemedicine (SHLT)$45M
CareCloud (CCLD)$44M